Checkpoint Therapeutics, Inc. Profile Avatar - Palmy Investing

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candi…

Biotechnology
US, Waltham [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CKPT's Analysis
CIK: 1651407 CUSIP: 162828107 ISIN: US1628282063 LEI: - UEI: -
Secondary Listings
CKPT has no secondary listings inside our databases.